Mentice AB (publ) (STO: MNTC)
Sweden flag Sweden · Delayed Price · Currency is SEK
21.00
-0.10 (-0.47%)
Nov 21, 2024, 3:39 PM CET

Mentice AB Company Description

Mentice AB (publ) provides endovascular simulation technology solutions in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas.

The company operates through three segments: Systems, Software Licenses and Service. It offers software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced, essential, and intermediate, left atrial appendage occlusion, neurovascular coiling and thrombectomy, peripheral angiography, prostatic artery embolization, radiation safety, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, peripheral angiography, and vascular trauma and cardiac rhythm management, as well as supports interventionalists to transition from transfemoral to transradial access.

The company also provides simulator accessories and extensions for endovascular therapies; cardiovascular; neurovascular; peripheral vascular solutions; mentice right heart cath app, a mobile solution for an interactive real-time exploration into the right heart catheterization procedure; mentice live learning center, a cloud based learning center for medical technology industry and healthcare provider; and angio suites and robotic integrators.

Mentice AB (publ) was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

Mentice AB (publ)
Country Sweden
Founded 1998
Industry Medical Devices
Sector Healthcare
Employees 122
CEO Göran Malmberg

Contact Details

Address:
Odinsgatan 10
Gothenburg, 411 03
Sweden
Phone 46 20 38 85 16 01
Website mentice.com

Stock Details

Ticker Symbol MNTC
Exchange Nasdaq Stockholm
Fiscal Year January - December
Reporting Currency SEK
ISIN Number SE0012673291
SIC Code 7372

Key Executives

Name Position
Göran Malmberg Group Chief Executive Officer and President
Ulrika Drotz Voksepp Chief Financial Officer
Jonatan Sjostrom Chief Operating Officer
Henrik Storm Chief Technology Officer
Martin Harris Vice President of Marketing
Matar Dakhil Executive Vice President of Business Development
Edward Fält Chief Strategy Officer
Stacy Hammar Corporate Marketing Manager of Medical Device
Dominic Steffel Senior Product Manager